Metabolomic Diagnostics raises €2 million in funding
Irish biotech company Metabolomic Diagnostics has secured an additional €2 million in venture funding to help complete PrePsia, its new screening test for first-time pregnant mothers.
Independent journalism every day
With digital access you can read The Business Post whenever, wherever, and however you want.
- Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
- Breaking news, comment and analysis from the best Business Post writers seven days a week.
- Live blogs of major news events
- Videos and podcasts from some of the industry's most respected journalists such as Tom Lyons, Susan Mitchell and Ian Guider
- Access to The Business Post's extensive archive
